Guido Oelkers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Swedish Orphan Biovitrum AB: Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024

Swedish Orphan Biovitrum AB: Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAnnette clancyStefan klotterGuido oelkersBo jesper hansenGerard tobinSobi investor relations teamNorth americaMiddle eastSobi mediaDie performance strategieAssets sie

Swedish Orphan Biovitrum Q3 Profit Tumbles, Reaffirms FY23 Outlook

Swedish Orphan Biovitrum AB (SWTUY.PK), a Swedish drug maker focused on the treatments in the areas of haematology, immunology and specialty care, on Monday registered a decline in profit for the third-quarter of 2023, amidst higher expenses and net financial items.

Guido oelkersSwedish orphan biovitrumSwedish orphan

Swedish Orphan Biovitrum AB: Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer

Swedish Orphan Biovitrum AB: Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTobias cottmannGuido oelkersLydia abad franchUniversity carlosHead of researchNovo nordiskSobi investor relations teamSchool of medicineSobi executive committeeUniversity of valenciaSenior vice presidentMedical affairsChief medicalSobi executiveNorth america

Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced the appointment of Lydia Abad-Franch, MD, MBA as Senior Vice President,.

United statesGuido oelkersLydia abad franchTobias cottmannSchool of medicineSobi investor relations teamHead of researchUniversity carlosUniversity of valenciaSobi executive committeeNovo nordiskSenior vice presidentMedical affairsChief medicalSobi executiveNorth america

Sobi KOL investor event: Advancing the standard of care in haemophilia

/PRNewswire/ Sobi invites investors to participate in a virtual KOL haemophilia event on 18 September 2023 at 15:00 CEST. Guido Oelkers, Chief Executive.

United kingdomUnited statesPrnewswire sobiLydia abad franchRobert klamrothGuido oelkersSobi investor relations teamChief executive officerChief medical officerKey opinion leaderChief physicianInternal medicineNorth americaMiddle eastSobi mediaOrphan biovitrum